Acoramidis beneficial in transthyretin amyloid cardiomyopathy
Acoramidis yields a significantly better four-step primary hierarchical outcome, including aspects of mortality and morbidity, than placebo for patients with transthyretin amyloid cardiomyopathy, according to a study published ...
Jan 14, 2024
0
6